Literature DB >> 2579028

Unresponsiveness to experimental allergic encephalomyelitis in Lewis rats pretreated with complete Freund's adjuvant.

K Hempel, A Freitag, B Freitag, B Endres, B Mai, G Liebaldt.   

Abstract

A single injection of complete Freund's adjuvant blended with aluminum hydroxide gel (ALU-CFA) was successfully used to prevent clinical as well as histologic experimental allergic encephalomyelitis (EAE) in Lewis rats for more than 330 days. Adjuvant preparations with Mycobacterium tuberculosis were more potent than those with Mycobacterium butyricum. Neither the removal of the ALU-CFA inoculum nor a splenectomy 1 month after immunization arrested the adjuvant induced unresponsiveness. However cyclophosphamide restored responsiveness in more than half of the treated animals when applied 2 days before the encephalitogenic challenge at a dose of 20 mg/kg. Passive EAE was not prevented by the ALU-CFA pretreatment. The disease was induced by the transfer of 4 X 10(6) T lymphocytes of a cell line reactive against myelin basic protein. This indicates that the adjuvant prevents EAE at the inductive rather than at the effector phase of the autoimmune response.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2579028     DOI: 10.1159/000233691

Source DB:  PubMed          Journal:  Int Arch Allergy Appl Immunol        ISSN: 0020-5915


  9 in total

Review 1.  The 'hygiene hypothesis' for autoimmune and allergic diseases: an update.

Authors:  H Okada; C Kuhn; H Feillet; J-F Bach
Journal:  Clin Exp Immunol       Date:  2010-04       Impact factor: 4.330

2.  Adjuvant immunotherapy of experimental autoimmune encephalomyelitis: immature myeloid cells expressing CXCL10 and CXCL16 attract CXCR3+CXCR6+ and myelin-specific T cells to the draining lymph nodes rather than the central nervous system.

Authors:  Richard A O'Connor; Xujian Li; Seth Blumerman; Stephen M Anderton; Randolph J Noelle; Dyana K Dalton
Journal:  J Immunol       Date:  2012-01-27       Impact factor: 5.422

3.  A T-cell dormant state in the autoimmune process of nonobese diabetic mice treated with complete Freund's adjuvant.

Authors:  D Ulaeto; P E Lacy; D M Kipnis; O Kanagawa; E R Unanue
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

4.  Induction of experimental autoimmune encephalomyelitis in Dark Agouti rats without adjuvant.

Authors:  S Stosic-Grujicic; Z Ramic; V Bumbasirevic; L Harhaji; M Mostarica-Stojkovic
Journal:  Clin Exp Immunol       Date:  2004-04       Impact factor: 4.330

Review 5.  Stress proteins: their role in the normal central nervous system and in disease states, especially multiple sclerosis.

Authors:  G Birnbaum
Journal:  Springer Semin Immunopathol       Date:  1995

6.  Resolution of acute inflammation bridges the gap between innate and adaptive immunity.

Authors:  Justine Newson; Melanie Stables; Efthimia Karra; Frederick Arce-Vargas; Sergio Quezada; Madhur Motwani; Matthias Mack; Simon Yona; Tatsiana Audzevich; Derek W Gilroy
Journal:  Blood       Date:  2014-07-08       Impact factor: 22.113

7.  Adjuvant immunotherapy is dependent on inducible nitric oxide synthase.

Authors:  D A Kahn; D C Archer; D P Gold; C J Kelly
Journal:  J Exp Med       Date:  2001-06-04       Impact factor: 14.307

8.  A T helper cell 2 (Th2) immune response against non-self antigens modifies the cytokine profile of autoimmune T cells and protects against experimental allergic encephalomyelitis.

Authors:  M Falcone; B R Bloom
Journal:  J Exp Med       Date:  1997-03-03       Impact factor: 14.307

9.  Conventional housing conditions attenuate the development of experimental autoimmune encephalomyelitis.

Authors:  Andreas Arndt; Peter Hoffacker; Konstantin Zellmer; Oktay Goecer; Mascha S Recks; Stefanie Kuerten
Journal:  PLoS One       Date:  2014-06-11       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.